← Narratives
BULLISH STABLE SPX

Technology sector stocks are experiencing significant analyst price target upgrades, indicating improved growth prospects

ARTICLES2
SOURCES1
SHARE0.0%
MOMENTUM 0pp
FIRST SEENJul 7, 2026
LAST SEENAug 8, 2026
→ TRAJECTORY Quiet

Too little corroboration in the last 3 days to call a trend (2 articles). Watching for it to gain traction.

COVERAGE OVER TIME
0.0%7.5%15.0% Jul 7Jul 14Jul 21Jul 28Aug 4Aug 11Aug 18Aug 25
COVERAGE MIX
Unclassified 2
RELATED THEMES

Themes moving alongside this one — where the same story is bleeding across assets, and where it's contested.

⚔ COMPETING Analyst target prices may be inflated and unrealistic, particularly when stocks have fallen and analysts maintain bullish views BEARISH SPX ⇄ CROSS-ASSET Tech companies must deliver strong profit growth in upcoming earnings to justify the significant stock price gains and valuations near record levels NEUTRAL GOOGL ⇄ CROSS-ASSET Tech Sector Earnings-Driven Rally BULLISH NDX ⇄ CROSS-ASSET Microsoft's strong Azure growth and analyst price target increases suggest underlying business strength despite near-term stock weakness BULLISH NDX ⇄ CROSS-ASSET Expected earnings improvement and analyst price target increases suggest upside potential despite current consensus Hold rating BULLISH NDX ≈ RELATED S&P 500 Tech-Led Record Rally BULLISH SPX
SOURCE EVIDENCE

"Stocks with material positive revisions to their average target prices over the past month include: Fortinet Inc. (FTNT-Q), increased 40 per cent to $162.69 from $116.03; Baxter International Inc. (BAX-N), increased 39 per cent to $28.10 from $20.18; Humana Inc. (HUM-N), increased 34 per cent to $408.88 from $305.48."

The Globe and Mail unknown Source article

"Stocks with material positive revisions to their average target prices over the past month include numerous technology stocks: Hewlett Packard (HPE-N), increased 126 per cent to US$68.60 from US$30.33; Micron Technology Inc. (MU-Q), increased 116 per cent to US$1,563.83 from US$722.49"

The Globe and Mail unknown Source article